SHOULD WE ANTICOAGULATE PATIENTS WITH ADVANCED SYSTOLIC HEART FAILURE WITHOUT ATRIAL FIBRILLATION? INSIGHTS FROM THE BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (BEST)

✍ Scribed by Marjan U. Mujib; Mustafa I. Ahmed; Wilbert S. Aronow; Prakash Deedwania; Ali Ahmed

• Book ID: 118579902
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 82 KB
• Volume: 55
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(10)60319-1